Skip to main content
PMC home page
The Journal of Clinical Investigation logoLink to The Journal of Clinical Investigation
. 1997 Nov 1;100(9):2333–2340. doi: 10.1172/JCI119772

Binding of beta-amyloid to the p75 neurotrophin receptor induces apoptosis. A possible mechanism for Alzheimer's disease.

M Yaar 1, S Zhai 1, P F Pilch 1, S M Doyle 1, P B Eisenhauer 1, R E Fine 1, B A Gilchrest 1
PMCID: PMC508430  PMID: 9410912

Abstract

Alzheimer's disease is a neurodegenerative disorder characterized by the extracellular deposition in the brain of aggregated beta-amyloid peptide, presumed to play a pathogenic role, and by preferential loss of neurons that express the 75-kD neurotrophin receptor (p75NTR). Using rat cortical neurons and NIH-3T3 cell line engineered to stably express p75NTR, we find that the beta-amyloid peptide specifically binds the p75NTR. Furthermore, 3T3 cells expressing p75NTR, but not wild-type control cells lacking the receptor, undergo apoptosis in the presence of aggregated beta-amyloid. Normal neural crest-derived melanocytes that express physiologic levels of p75NTR undergo apoptosis in the presence of aggregated beta-amyloid, but not in the presence of control peptide synthesized in reverse. These data imply that neuronal death in Alzheimer's disease is mediated, at least in part, by the interaction of beta-amyloid with p75NTR, and suggest new targets for therapeutic intervention.

Full Text

The Full Text of this article is available as a PDF (486.4 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baldwin A. N., Shooter E. M. Zone mapping of the binding domain of the rat low affinity nerve growth factor receptor by the introduction of novel N-glycosylation sites. J Biol Chem. 1995 Mar 3;270(9):4594–4602. doi: 10.1074/jbc.270.9.4594. [DOI] [PubMed] [Google Scholar]
  2. Barinaga M. Missing Alzheimer's gene found. Science. 1995 Aug 18;269(5226):917–918. doi: 10.1126/science.7638610. [DOI] [PubMed] [Google Scholar]
  3. Battleman D. S., Geller A. I., Chao M. V. HSV-1 vector-mediated gene transfer of the human nerve growth factor receptor p75hNGFR defines high-affinity NGF binding. J Neurosci. 1993 Mar;13(3):941–951. doi: 10.1523/JNEUROSCI.13-03-00941.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Bauer J., Hüll M., Berger M. Pathogenetische Faktoren der Alzheimer-Krankheit. Z Gerontol Geriatr. 1995 May-Jun;28(3):155–155. [PubMed] [Google Scholar]
  5. Behl C., Davis J. B., Klier F. G., Schubert D. Amyloid beta peptide induces necrosis rather than apoptosis. Brain Res. 1994 May 9;645(1-2):253–264. doi: 10.1016/0006-8993(94)91659-4. [DOI] [PubMed] [Google Scholar]
  6. Behl C., Davis J. B., Lesley R., Schubert D. Hydrogen peroxide mediates amyloid beta protein toxicity. Cell. 1994 Jun 17;77(6):817–827. doi: 10.1016/0092-8674(94)90131-7. [DOI] [PubMed] [Google Scholar]
  7. Benedetti M., Levi A., Chao M. V. Differential expression of nerve growth factor receptors leads to altered binding affinity and neurotrophin responsiveness. Proc Natl Acad Sci U S A. 1993 Aug 15;90(16):7859–7863. doi: 10.1073/pnas.90.16.7859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Boland K., Behrens M., Choi D., Manias K., Perlmutter D. H. The serpin-enzyme complex receptor recognizes soluble, nontoxic amyloid-beta peptide but not aggregated, cytotoxic amyloid-beta peptide. J Biol Chem. 1996 Jul 26;271(30):18032–18044. doi: 10.1074/jbc.271.30.18032. [DOI] [PubMed] [Google Scholar]
  9. Boldin M. P., Varfolomeev E. E., Pancer Z., Mett I. L., Camonis J. H., Wallach D. A novel protein that interacts with the death domain of Fas/APO1 contains a sequence motif related to the death domain. J Biol Chem. 1995 Apr 7;270(14):7795–7798. doi: 10.1074/jbc.270.14.7795. [DOI] [PubMed] [Google Scholar]
  10. Casaccia-Bonnefil P., Carter B. D., Dobrowsky R. T., Chao M. V. Death of oligodendrocytes mediated by the interaction of nerve growth factor with its receptor p75. Nature. 1996 Oct 24;383(6602):716–719. doi: 10.1038/383716a0. [DOI] [PubMed] [Google Scholar]
  11. Chao M. V., Hempstead B. L. p75 and Trk: a two-receptor system. Trends Neurosci. 1995 Jul;18(7):321–326. [PubMed] [Google Scholar]
  12. Cheng B., Mattson M. P. Glucose deprivation elicits neurofibrillary tangle-like antigenic changes in hippocampal neurons: prevention by NGF and bFGF. Exp Neurol. 1992 Aug;117(2):114–123. doi: 10.1016/0014-4886(92)90120-f. [DOI] [PubMed] [Google Scholar]
  13. Cheng B., Mattson M. P. NGF and bFGF protect rat hippocampal and human cortical neurons against hypoglycemic damage by stabilizing calcium homeostasis. Neuron. 1991 Dec;7(6):1031–1041. doi: 10.1016/0896-6273(91)90347-3. [DOI] [PubMed] [Google Scholar]
  14. Cortazzo M. H., Kassis E. S., Sproul K. A., Schor N. F. Nerve growth factor (NGF)-mediated protection of neural crest cells from antimitotic agent-induced apoptosis: the role of the low-affinity NGF receptor. J Neurosci. 1996 Jun 15;16(12):3895–3899. doi: 10.1523/JNEUROSCI.16-12-03895.1996. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Cotman C. W., Anderson A. J. A potential role for apoptosis in neurodegeneration and Alzheimer's disease. Mol Neurobiol. 1995 Feb;10(1):19–45. doi: 10.1007/BF02740836. [DOI] [PubMed] [Google Scholar]
  16. Crowley C., Spencer S. D., Nishimura M. C., Chen K. S., Pitts-Meek S., Armanini M. P., Ling L. H., McMahon S. B., Shelton D. L., Levinson A. D. Mice lacking nerve growth factor display perinatal loss of sensory and sympathetic neurons yet develop basal forebrain cholinergic neurons. Cell. 1994 Mar 25;76(6):1001–1011. doi: 10.1016/0092-8674(94)90378-6. [DOI] [PubMed] [Google Scholar]
  17. Davis-Salinas J., Van Nostrand W. E. Amyloid beta-protein aggregation nullifies its pathologic properties in cultured cerebrovascular smooth muscle cells. J Biol Chem. 1995 Sep 8;270(36):20887–20890. doi: 10.1074/jbc.270.36.20887. [DOI] [PubMed] [Google Scholar]
  18. Deckwerth T. L., Johnson E. M., Jr Temporal analysis of events associated with programmed cell death (apoptosis) of sympathetic neurons deprived of nerve growth factor. J Cell Biol. 1993 Dec;123(5):1207–1222. doi: 10.1083/jcb.123.5.1207. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Du Yan S., Zhu H., Fu J., Yan S. F., Roher A., Tourtellotte W. W., Rajavashisth T., Chen X., Godman G. C., Stern D. Amyloid-beta peptide-receptor for advanced glycation endproduct interaction elicits neuronal expression of macrophage-colony stimulating factor: a proinflammatory pathway in Alzheimer disease. Proc Natl Acad Sci U S A. 1997 May 13;94(10):5296–5301. doi: 10.1073/pnas.94.10.5296. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. El Khoury J., Hickman S. E., Thomas C. A., Cao L., Silverstein S. C., Loike J. D. Scavenger receptor-mediated adhesion of microglia to beta-amyloid fibrils. Nature. 1996 Aug 22;382(6593):716–719. doi: 10.1038/382716a0. [DOI] [PubMed] [Google Scholar]
  21. Feinstein E., Kimchi A., Wallach D., Boldin M., Varfolomeev E. The death domain: a module shared by proteins with diverse cellular functions. Trends Biochem Sci. 1995 Sep;20(9):342–344. doi: 10.1016/s0968-0004(00)89070-2. [DOI] [PubMed] [Google Scholar]
  22. Frade J. M., Rodríguez-Tébar A., Barde Y. A. Induction of cell death by endogenous nerve growth factor through its p75 receptor. Nature. 1996 Sep 12;383(6596):166–168. doi: 10.1038/383166a0. [DOI] [PubMed] [Google Scholar]
  23. Gall C. M., Isackson P. J. Limbic seizures increase neuronal production of messenger RNA for nerve growth factor. Science. 1989 Aug 18;245(4919):758–761. doi: 10.1126/science.2549634. [DOI] [PubMed] [Google Scholar]
  24. Gavrieli Y., Sherman Y., Ben-Sasson S. A. Identification of programmed cell death in situ via specific labeling of nuclear DNA fragmentation. J Cell Biol. 1992 Nov;119(3):493–501. doi: 10.1083/jcb.119.3.493. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Glenner G. G., Wong C. W. Alzheimer's disease: initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun. 1984 May 16;120(3):885–890. doi: 10.1016/s0006-291x(84)80190-4. [DOI] [PubMed] [Google Scholar]
  26. Goldstein R. S., Avivi C., Geffen R. In vivo NGF treatment increases proliferation in the primary sympathetic ganglia of chick embryos. Dev Biol. 1997 Jan 1;181(1):116–120. doi: 10.1006/dbio.1996.8456. [DOI] [PubMed] [Google Scholar]
  27. Gray C. W., Patel A. J. Neurodegeneration mediated by glutamate and beta-amyloid peptide: a comparison and possible interaction. Brain Res. 1995 Sep 11;691(1-2):169–179. doi: 10.1016/0006-8993(95)00669-h. [DOI] [PubMed] [Google Scholar]
  28. Gschwind M., Martin J. R., Moreau J. L., Huber G. beta-APP cognitive function versus beta-amyloid--induced cell death. Ann N Y Acad Sci. 1996 Jan 17;777:293–296. doi: 10.1111/j.1749-6632.1996.tb34435.x. [DOI] [PubMed] [Google Scholar]
  29. Henderson T. A., Rhoades R. W., Bennett-Clarke C. A., Osborne P. A., Johnson E. M., Jacquin M. F. NGF augmentation rescues trigeminal ganglion and principalis neurons, but not brainstem or cortical whisker patterns, after infraorbital nerve injury at birth. J Comp Neurol. 1993 Oct 8;336(2):243–260. doi: 10.1002/cne.903360207. [DOI] [PubMed] [Google Scholar]
  30. Jiang Z. G., Smith R. A. Effects of nerve growth factor on the survival of primary cultured adult and aged mouse sensory neurons. J Neurosci Res. 1993 May 1;35(1):29–37. doi: 10.1002/jnr.490350105. [DOI] [PubMed] [Google Scholar]
  31. Kawaja M. D., Rosenberg M. B., Yoshida K., Gage F. H. Somatic gene transfer of nerve growth factor promotes the survival of axotomized septal neurons and the regeneration of their axons in adult rats. J Neurosci. 1992 Jul;12(7):2849–2864. doi: 10.1523/JNEUROSCI.12-07-02849.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Lapchak P. A. Nerve growth factor pharmacology: application to the treatment of cholinergic neurodegeneration in Alzheimer's disease. Exp Neurol. 1993 Nov;124(1):16–20. doi: 10.1006/exnr.1993.1168. [DOI] [PubMed] [Google Scholar]
  33. Levy-Lahad E., Wijsman E. M., Nemens E., Anderson L., Goddard K. A., Weber J. L., Bird T. D., Schellenberg G. D. A familial Alzheimer's disease locus on chromosome 1. Science. 1995 Aug 18;269(5226):970–973. doi: 10.1126/science.7638621. [DOI] [PubMed] [Google Scholar]
  34. Lärkfors L., Ebendal T., Whittemore S. R., Persson H., Hoffer B., Olson L. Decreased level of nerve growth factor (NGF) and its messenger RNA in the aged rat brain. Brain Res. 1987 Dec;427(1):55–60. doi: 10.1016/0169-328x(87)90044-1. [DOI] [PubMed] [Google Scholar]
  35. Mahadeo D., Kaplan L., Chao M. V., Hempstead B. L. High affinity nerve growth factor binding displays a faster rate of association than p140trk binding. Implications for multi-subunit polypeptide receptors. J Biol Chem. 1994 Mar 4;269(9):6884–6891. [PubMed] [Google Scholar]
  36. Manfridi A., Forloni G. L., Arrigoni-Martelli E., Mancia M. Culture of dorsal root ganglion neurons from aged rats: effects of acetyl-L-carnitine and NGF. Int J Dev Neurosci. 1992 Aug;10(4):321–329. doi: 10.1016/0736-5748(92)90021-q. [DOI] [PubMed] [Google Scholar]
  37. Nagata S., Golstein P. The Fas death factor. Science. 1995 Mar 10;267(5203):1449–1456. doi: 10.1126/science.7533326. [DOI] [PubMed] [Google Scholar]
  38. Olson L., Nordberg A., von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A. Nerve growth factor affects 11C-nicotine binding, blood flow, EEG, and verbal episodic memory in an Alzheimer patient (case report). J Neural Transm Park Dis Dement Sect. 1992;4(1):79–95. doi: 10.1007/BF02257624. [DOI] [PubMed] [Google Scholar]
  39. Paresce D. M., Ghosh R. N., Maxfield F. R. Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron. 1996 Sep;17(3):553–565. doi: 10.1016/s0896-6273(00)80187-7. [DOI] [PubMed] [Google Scholar]
  40. Peacocke M., Yaar M., Mansur C. P., Chao M. V., Gilchrest B. A. Induction of nerve growth factor receptors on cultured human melanocytes. Proc Natl Acad Sci U S A. 1988 Jul;85(14):5282–5286. doi: 10.1073/pnas.85.14.5282. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Pike C. J., Burdick D., Walencewicz A. J., Glabe C. G., Cotman C. W. Neurodegeneration induced by beta-amyloid peptides in vitro: the role of peptide assembly state. J Neurosci. 1993 Apr;13(4):1676–1687. doi: 10.1523/JNEUROSCI.13-04-01676.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Rabizadeh S., Bitler C. M., Butcher L. L., Bredesen D. E. Expression of the low-affinity nerve growth factor receptor enhances beta-amyloid peptide toxicity. Proc Natl Acad Sci U S A. 1994 Oct 25;91(22):10703–10706. doi: 10.1073/pnas.91.22.10703. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Ruit K. G., Osborne P. A., Schmidt R. E., Johnson E. M., Jr, Snider W. D. Nerve growth factor regulates sympathetic ganglion cell morphology and survival in the adult mouse. J Neurosci. 1990 Jul;10(7):2412–2419. doi: 10.1523/JNEUROSCI.10-07-02412.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  44. Seiger A., Nordberg A., von Holst H., Bäckman L., Ebendal T., Alafuzoff I., Amberla K., Hartvig P., Herlitz A., Lilja A. Intracranial infusion of purified nerve growth factor to an Alzheimer patient: the first attempt of a possible future treatment strategy. Behav Brain Res. 1993 Nov 30;57(2):255–261. doi: 10.1016/0166-4328(93)90141-c. [DOI] [PubMed] [Google Scholar]
  45. Selkoe D. J. Amyloid beta-protein and the genetics of Alzheimer's disease. J Biol Chem. 1996 Aug 2;271(31):18295–18298. doi: 10.1074/jbc.271.31.18295. [DOI] [PubMed] [Google Scholar]
  46. Selkoe D. J. Normal and abnormal biology of the beta-amyloid precursor protein. Annu Rev Neurosci. 1994;17:489–517. doi: 10.1146/annurev.ne.17.030194.002421. [DOI] [PubMed] [Google Scholar]
  47. Selkoe D. J. The molecular pathology of Alzheimer's disease. Neuron. 1991 Apr;6(4):487–498. doi: 10.1016/0896-6273(91)90052-2. [DOI] [PubMed] [Google Scholar]
  48. Shimohama S., Ogawa N., Tamura Y., Akaike A., Tsukahara T., Iwata H., Kimura J. Protective effect of nerve growth factor against glutamate-induced neurotoxicity in cultured cortical neurons. Brain Res. 1993 Dec 31;632(1-2):296–302. doi: 10.1016/0006-8993(93)91164-n. [DOI] [PubMed] [Google Scholar]
  49. Su J. H., Anderson A. J., Cummings B. J., Cotman C. W. Immunohistochemical evidence for apoptosis in Alzheimer's disease. Neuroreport. 1994 Dec 20;5(18):2529–2533. doi: 10.1097/00001756-199412000-00031. [DOI] [PubMed] [Google Scholar]
  50. Takahashi Y. Gene expression in cells of the central nervous system. Prog Neurobiol. 1992 Jun;38(6):523–569. doi: 10.1016/0301-0082(92)90041-c. [DOI] [PubMed] [Google Scholar]
  51. Tuszynski M. H., U H. S., Amaral D. G., Gage F. H. Nerve growth factor infusion in the primate brain reduces lesion-induced cholinergic neuronal degeneration. J Neurosci. 1990 Nov;10(11):3604–3614. doi: 10.1523/JNEUROSCI.10-11-03604.1990. [DOI] [PMC free article] [PubMed] [Google Scholar]
  52. Waugh S. M., DiBella E. E., Pilch P. F. Isolation of a proteolytically derived domain of the insulin receptor containing the major site of cross-linking/binding. Biochemistry. 1989 Apr 18;28(8):3448–3455. doi: 10.1021/bi00434a045. [DOI] [PubMed] [Google Scholar]
  53. Woolf N. J., Gould E., Butcher L. L. Nerve growth factor receptor is associated with cholinergic neurons of the basal forebrain but not the pontomesencephalon. Neuroscience. 1989;30(1):143–152. doi: 10.1016/0306-4522(89)90360-6. [DOI] [PubMed] [Google Scholar]
  54. Yaar M., Eller M. S., DiBenedetto P., Reenstra W. R., Zhai S., McQuaid T., Archambault M., Gilchrest B. A. The trk family of receptors mediates nerve growth factor and neurotrophin-3 effects in melanocytes. J Clin Invest. 1994 Oct;94(4):1550–1562. doi: 10.1172/JCI117496. [DOI] [PMC free article] [PubMed] [Google Scholar]
  55. Yamazaki T., Selkoe D. J., Koo E. H. Trafficking of cell surface beta-amyloid precursor protein: retrograde and transcytotic transport in cultured neurons. J Cell Biol. 1995 Apr;129(2):431–442. doi: 10.1083/jcb.129.2.431. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Yan S. D., Chen X., Fu J., Chen M., Zhu H., Roher A., Slattery T., Zhao L., Nagashima M., Morser J. RAGE and amyloid-beta peptide neurotoxicity in Alzheimer's disease. Nature. 1996 Aug 22;382(6593):685–691. doi: 10.1038/382685a0. [DOI] [PubMed] [Google Scholar]
  57. Yankner B. A., Caceres A., Duffy L. K. Nerve growth factor potentiates the neurotoxicity of beta amyloid. Proc Natl Acad Sci U S A. 1990 Nov;87(22):9020–9023. doi: 10.1073/pnas.87.22.9020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  58. Zhai S., Yaar M., Doyle S. M., Gilchrest B. A. Nerve growth factor rescues pigment cells from ultraviolet-induced apoptosis by upregulating BCL-2 levels. Exp Cell Res. 1996 May 1;224(2):335–343. doi: 10.1006/excr.1996.0143. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Clinical Investigation are provided here courtesy of American Society for Clinical Investigation

RESOURCES